Related Experiment Video
Updated: May 22, 2026

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation
Maria Carolina Florian1, Karin Dörr, Anja Niebel
1Department of Dermatology and Allergic Diseases, University of Ulm, 89091 Ulm, Germany.
Aging hematopoietic stem cells (HSCs) show increased Cdc42 activity, impairing immune function and increasing cancer risk. Inhibiting Cdc42 rejuvenates aged HSCs and restores youthful epigenetic patterns.
Area of Science:
- Hematology
- Stem Cell Biology
- Epigenetics
Background:
- Aging hematopoietic stem cells (HSCs) exhibit declining function, reduced immunity, and increased myeloid malignancy risk.
- The molecular drivers of HSC aging are not fully understood.
Purpose of the Study:
- To investigate the role of the small RhoGTPase Cdc42 in HSC aging.
- To explore Cdc42's impact on HSC polarity and epigenetic regulation.
Main Methods:
- Assessed Cdc42 activity in aged HSCs.
- Utilized pharmacological inhibition of Cdc42.
- Analyzed cell polarity and histone H4 lysine 16 acetylation levels.
Main Results:
- Elevated Cdc42 activity in aged HSCs correlates with loss of cell polarity.
- Pharmacological inhibition of Cdc42 rejuvenated aged HSCs.
- Cdc42 inhibition restored normal histone acetylation patterns in aged HSCs.
Conclusions:
- Cdc42 activity is mechanistically linked to HSC aging and epigenetic dysregulation.
- Targeting Cdc42 activity offers a potential therapeutic strategy for stem cell aging.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Inhibition of Cdk Activity
Replicative Cell Senescence
Replicative Cell Senescence
Lineage Commitment

